111, Inc. (NASDAQ:YI) traded at $5.75 at last check on Monday, Sep 14, making an upward move of 3.23% on its previous day’s price.

Looking at the stock we see that its previous close was $5.57 and the beta (5Y monthly) reads 0 with the day’s price range being $5.42 – 6.34. The company has a 12-month trailing PE ratio of 0. In terms of its 52-week price range, YI has a high of $8.7 and a low of $4.26. The company’s stock has gained about -13.92% over that past 30 days.

111, has a market cap of $485.19 Million and is expected to release its quarterly earnings report on Nov 12, 2020- Nov 16, 2020. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the YI stock to lose ahead of the earnings release. Estimates by analysts give the company expected earnings per share (EPS) of $0, with the EPS growth for the year raised at -$0.33 for 2020 and -$0.24 for next year. These figures represent -0.56% and at -0.27% growth in EPS for the two years respectively.

On the other hand, looking at the outlook for the YI stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 50% Sell.

Based on estimates by 1 analysts where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, none have rated the 111, Inc. (YI) stock as a Hold, while 1 rate it as a Buy. None analysts rate it as outperform while none of them rated it as underperform, whereas none suggests the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.

Let’s briefly compare 111, (YI) stock to its peers. We find that today’s price change of +3.23% and +15.23% over the past 12 months for YI betters that of Cerner Corp (CERN), which has seen its stock price rise 1.4% in the latest trading session and is +6.03% over the last one year. Another of its peers 10X Genomics Inc (TXG) has dropped -3.27% today, and is +131.32% up over the past year, while Livongo Health Inc (LVGO) is also up 3.23% yet its price remains in the green at 15.23% over the same period. Cerner has a P/E ratio of 43.39 compared to 111,’s 0 and 10X’s 0. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 1.27% and 1.18%, respectively, in early deals.

Coming back to 111, Inc. (NASDAQ:YI), we note that the average 3-month trading volume was 108.32 Million, while that of the preceding 10-day period stands at 64.22 Million. Current shares outstanding are 82.36 Million.

According to data from Thomson Reuters, insiders hold 0% of the company’s shares while institutions hold 5.57%. The data shows that short shares as of August 30, 2020, stood at 72.76 Million at a short ratio of 0.69. This represents a 0.09% Short interest in Shares outstanding on August 30, 2020. Shares short dropped in August from the previous month at 76.87 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -14.56% down in year-to-date price movement.